Regulation of pituitary V1b vasopressin receptor messenger ribonucleic acid by adrenalectomy and glucocorticoid administration

被引:36
|
作者
RabadanDiehl, C
Makara, G
Kiss, A
Lolait, S
Zelena, D
Ochedalski, T
Aguilera, G
机构
[1] NICHHD, SECT ENDOCRINE PHYSIOL, DEV ENDOCRINOL BRANCH, NIH, BETHESDA, MD 20892 USA
[2] HUNGARIAN ACAD SCI, INST EXPT MED, H-1450 BUDAPEST, HUNGARY
[3] NIMH, LAB MOL & CELLULAR REGULAT, NIH, BETHESDA, MD 20892 USA
关键词
D O I
10.1210/en.138.12.5189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Regulation of the number of pituitary vasopressin (VP) receptors plays an important role in controlling pituitary responsiveness during alterations of the hypothalamic pituitary adrenal axis. The mechanisms regulating these VP receptors were studied by analysis of the effects of adrenalectomy and glucocorticoid administration on V1b receptor (V1b-R) messenger RNA (mRNA) by Northern blot and by in situ hybridization in the rat. Adrenalectomy transiently decreased V1b-R mRNA levels by 18 h (77% and 62% for the 3.7-kb and 3.2-kb bands in the Northern blots, and 50% by in situ hybridization), returning to basal levels after 6 days. The decrease in V1b-R mRNA after 18 h adrenalectomy was fully prevented by dexamethasone (100 mu g sc) but not by elimination of hypothalamic CRH and VP by paraventricular nucleus lesions or median eminence deafferentation. In sham-operated rats, dexamethasone increased receptor mRNA by 50% after 6 days. In contrast to Sprague-Dawley rats, in Brattleboro rats (di/di), which lack hypothalamic VP, adrenalectomy caused a sustained decrease in V1b-R mRNA levels (<50% of controls by 6 days). The data show that pituitary V1b-R mRNA is positively regulated by glucocorticoids and that the recovery of V1b-R mRNA levels after prolonged adrenalectomy is probably mediated by VP. In addition, the data suggest that the down-regulation of VP binding after long-term adrenalectomy is due to posttranscriptional events rather than to changes in V1b-R mRNA.
引用
收藏
页码:5189 / 5194
页数:6
相关论文
共 50 条
  • [1] Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain
    Vaccari, C
    Lolait, SJ
    Ostrowski, NL
    ENDOCRINOLOGY, 1998, 139 (12) : 5015 - 5033
  • [2] Regulation of pituitary vasopressin V1b receptor mRNA during stress in the rat
    RabadanDiehl, C
    Lolait, SJ
    Aguilera, G
    JOURNAL OF NEUROENDOCRINOLOGY, 1995, 7 (12) : 903 - 910
  • [3] Transcriptional regulation of the pituitary vasopressin V1b receptor involves a GAGA-binding protein
    Volpi, S
    Rabadan-Diehl, C
    Cawley, N
    Aguilera, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (31) : 27829 - 27838
  • [4] Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat
    Aguilera, G
    Rabadan-Diehl, C
    EXPERIMENTAL PHYSIOLOGY, 2000, 85 : 19S - 26S
  • [5] Regulation of vasopressin V1b receptors and stress adaptation
    Volpi, S
    Rabadán-Diehl, C
    Aguilera, G
    STRESS: CURRENT NEUROENDOCRINE AND GENETIC APPROACHES, 2004, 1018 : 293 - 301
  • [6] Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor
    Ventura, MA
    René, P
    de Keyzer, Y
    Bertagna, X
    Clauser, E
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1999, 22 (03) : 251 - 260
  • [7] Characterization of vasopressin V1b receptor deficient mouse
    Oshikawa, S
    Tanoue, A
    Ito, S
    Fukuda, M
    Yamamoto, K
    Tsujimoto, G
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 213P - 213P
  • [8] Fluorescent agonists for the human vasopressin V1b receptor
    Guillon, G.
    Murat, B.
    Corbani, M.
    Boulay, V
    Stoev, S.
    Manning, M.
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 116 - 116
  • [9] Vasopressin V1B Receptor Antagonists as Potential Antidepressants
    Chaki, Shigeyuki
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (06): : 450 - 463
  • [10] Subcellular localization and internalization of the vasopressin V1B receptor
    Kashiwazaki, Aki
    Fujiwara, Yoko
    Tsuchiya, Hiroyoshi
    Sakai, Nobuya
    Shibata, Katsushi
    Koshimizu, Taka-aki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 765 : 291 - 299